The funding discussions highlight ongoing investor demand for new and unproven research labs looking to find novel approaches to AI that push the technology forward. Recursive’s goal is to develop ...

In mid-December 2025, an image (archived) circulated online purportedly showing U.S. President Donald Trump using a walker as a mobility aid. Keith Edwards, a Democratic political strategist, posted ...

What is it with lawyers and AI? We don’t know, but it feels like an inordinate number of them keep screwing up with AI tools, apparently never learning from their colleagues who get publicly crucified ...

Michael Legg does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

This AI company isn't yet living up to the hype. Let's discuss Recursion Pharmaceuticals' performance over the past four years and whether the company can deliver solid returns in the future. It can ...

Add Yahoo as a preferred source to see more of our stories on Google. A variation of a puzzle called the “pick-up sticks problem” asks the following question: If I have some number of sticks with ...

The VP of engineering at a leading technology company stared at the quarterly adoption metrics with growing frustration. Twelve months after rolling out a state-of-the-art AI coding assistant—a tool ...

SAN FRANCISCO, July 18 (Reuters) - Microsoft (MSFT.O), opens new tab on Friday said it will stop using China-based engineers to provide technical assistance to the U.S. military after a report in ...

When Fibonacci introduced what would become an eponymous sequence, he did so using rabbits as an analogy. Breeding pairs of rabbits are able to multiply within their ranks infinitely. Unfortunately, ...

Either way, let’s not be in denial about it. Credit...Illustration by Christoph Niemann Supported by By Kevin Roose and Casey Newton Kevin Roose and Casey Newton are the hosts of The Times’s “Hard ...

June 10 (Reuters) - Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding ...